TrialAllergy2022
Dupilumab improves health related quality of life: Results from the phase 3 SINUS studies.
Stella E Lee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
31 papers cite it
this papertrialcites it
TrialAllergy2022
Stella E Lee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.